Target N V Biotech Molecular Templates, Inc. (MTEM) insider trading activity

Target N V Biotech is of Molecular Templates, Inc.. Currently has a direct ownership of 0 shares of MTEM, which is worth approximately $0. The most recent transaction as insider was on Jan 29, 2021, when has been sold 80,000 shares (Common Stock) at a price of $11.94 per share, resulting in proceeds of $955,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

TARGET N V BIOTECH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2021	BUY Open market or private purchase	$955,200 $11.94 p/Share	80,000 Added 1.22%	6,460,331 Common Stock
Dec 10 2020	BUY Open market or private purchase	$2,652,800 $8.29 p/Share	320,000 Added 4.78%	6,380,331 Common Stock
Dec 09 2020	BUY Open market or private purchase	$1,077,500 $8.62 p/Share	125,000 Added 2.02%	6,060,331 Common Stock
Nov 10 2020	BUY Open market or private purchase	$732,800 $9.16 p/Share	80,000 Added 1.33%	5,935,331 Common Stock
Nov 09 2020	BUY Open market or private purchase	$724,000 $9.05 p/Share	80,000 Added 1.35%	5,855,331 Common Stock
Nov 06 2020	BUY Open market or private purchase	$3,917,891 $8.33 p/Share	470,335 Added 7.53%	5,775,331 Common Stock
Nov 05 2020	BUY Open market or private purchase	$814,500 $10.86 p/Share	75,000 Added 1.39%	5,304,996 Common Stock
Oct 30 2020	BUY Open market or private purchase	$706,400 $8.83 p/Share	80,000 Added 1.51%	5,229,996 Common Stock
Oct 28 2020	BUY Open market or private purchase	$752,000 $9.4 p/Share	80,000 Added 1.53%	5,149,996 Common Stock

Also insider at

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

RDUS

Radius Health, Inc. Healthcare

> 10% Shareholder

MGNX

MACROGENICS INC Healthcare

> 10% Shareholder

TNV